Form 4: Director Kevin Roe Receives Equity Grant at cbdMD
Statement of Changes in Beneficial Ownership
Director Kevin Roe was granted 1,572 restricted stock units as compensation for his service on the board of cbdMD, Inc.
Summary
- Director Kevin Roe acquired 1,572 restricted stock units (RSUs) on April 14, 2026.
- The RSUs represent a contingent right to receive one share of common stock per unit.
- The grant was issued as compensation for board services under the company's equity compensation plan.
- Following this transaction, the director's total beneficial ownership stands at 26,707 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Grant was approved by the Compensation, Corporate Governance and Nominating Committee, ensuring proper governance oversight.
Negatives
- None identified.
Risks
- General market risks associated with equity-based compensation and potential dilution.
Future Outlook
The RSUs are scheduled to vest in four equal quarterly installments beginning June 30, 2026, and concluding March 31, 2027.
Management Comments
- The grant was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practice to ensure long-term alignment between board members and shareholders, particularly in the volatile CBD and wellness sector.
Comparison to Industry Standards
- The use of quarterly vesting schedules for director equity is consistent with standard corporate governance practices for small-cap public companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Issuance of restricted stock units to a director under the 2021 or 2025 Equity Compensation Plan. | 04/14/2026 | Standard alignment of director compensation with company performance. |
Stakeholder Impact
- Shareholders: Minor dilution impact from the issuance of new equity.
Next Steps
- Vesting of the first tranche of RSUs on June 30, 2026.
Key Dates
| Date | Description |
|---|---|
| 04/14/2026 | Date of the RSU grant transaction. |
| 04/16/2026 | Date of filing. |
| 06/30/2026 | First quarterly vesting date for the RSUs. |
| 09/30/2026 | Second quarterly vesting date. |
| 12/31/2026 | Third quarterly vesting date. |
| 03/31/2027 | Final quarterly vesting date. |
Keywords
cbdMD, YCBD, Form 4, Insider Trading, Equity Compensation, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.